ERBB2 and breast carcinoma: To investigate the synergistic effects of ErbB2 inhibitor and cholesterol-lowering drug in vivo, we generated ErbB2-positive breast cancer xenograft mouse models by implanting HCC1954 cells into athymic nude mice.